yahoo news | Palantir Faces Burry Critique And UK Scrutiny As Anthropic Competition Grows

Investor Michael Burry has once again flagged Palantir Technologies (NASDAQ: PLTR) as a short, calling out the company’s premium AI valuation and pointing to Anthropic as a lower‑cost competitor that could erode Palantir’s claim to a market‑leading position in enterprise and government AI software. Anthropic’s rapid expansion of its own AI offerings adds pressure on Palantir, which has been trading far above its three‑year‑ago price despite a solid 53 % year‑to‑date return. The short‑seller’s argument is that the strong trailing performance may be overstated if Palantir cannot defend its pricing power against cheaper alternatives from Anthropic, OpenAI, Microsoft or Google.

At the same time, Palantir is confronting heightened scrutiny from UK regulators and ethics bodies over its government and NHS contracts. Questions about data‑privacy, defense‑sector usage and long‑term contract risk have surfaced, with the possibility that tighter rules, additional approval steps, or contractual restrictions could lengthen sales cycles and increase compliance costs. This regulatory spotlight coincides with broader public debate about the ethical use of AI in healthcare and defense, creating uncertainty for Palantir’s pipeline in a key overseas market.

Despite the headwinds, Palantir continues to secure large‑scale deals, such as renewed contracts with Stellantis, an expanded partnership with Bain & Company, and the Pentagon’s Maven program, suggesting that some enterprise and government customers still view its platform as core AI infrastructure. Investors are now watching whether UK regulatory actions translate into formal limits, how often Anthropic and other AI providers appear in procurement processes, and whether contract renewal patterns shift. The balance between these competitive and regulatory pressures will shape Palantir’s future revenue visibility and valuation.

Read more: https://finance.yahoo.com/markets/stocks/articles/palantir-faces-burry-critique-uk-031443109.html?fr=sycsrp_catchall

#palantir #michaelburry #anthropic #u.k.regulators #nhs

Palantir Faces Burry Critique And UK Scrutiny As Anthropic Competition Grows

Investor Michael Burry publicly reiterates a short position in Palantir Technologies, criticizing NasdaqGS:PLTR's premium AI valuation and highlighting...

Yahoo Finance